NCT03919071 2026-03-18
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Novartis
St. Joseph's Hospital and Medical Center, Phoenix
Mayo Clinic
Inovio Pharmaceuticals
Northwestern University
Sun Yat-sen University
University of Iowa
University of Iowa
Medical College of Wisconsin
Northwestern University
University of Pittsburgh
Mayo Clinic
St. Joseph's Hospital and Medical Center, Phoenix
Centre Jean Perrin